Beranda › Nefrosis Lipoid › Texas
Uji klinis Nefrosis Lipoid di Texas
4 studi untuk Nefrosis Lipoid mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.